Zar Technology Services

opxbiotechnologies.com

At OPXBIO, we’re in the Good Chemistry business. We develop and produce bio-based chemicals and fuels that deliver more sustainable value to our customers. Good Chemistry is everything we do. It is how we use our leading EDGE™ biotechnology to bring new products to market faster. It’s our strategic partnerships. It’s our high-performing team. And it’s our inspiration to transform the business of chemistry to a more sustainable future.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

DNA-ENCODED LIBRARIES (DELS) AND NANOBRET TARGET ENGAGEMENT ASSAYS ACCELERATE DRUG DISCOVERY

Businesswire | August 03, 2023

news image

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery. Reported in Cell Chemical Biology, researchers from Promega Corporation and WuXi AppTec generated new chemical probes from molecules identified through a DEL screen. This research opens new opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied classes of proteins, rapidly accelerating “h...

Read More

MedTech

ROCHE SIGNS AN AGREEMENT WITH SYSMEX TO BRING HAEMATOLOGY TESTING INNOVATIONS GLOBALLY

Roche | January 25, 2021

news image

Roche declares that, on 14 December, 2020, it marked a Global Business Partnership Agreement* (GBP) with Sysmex. Under this new system, the gatherings restored their obligation to the long standing Distribution, Sales and Service (DSS) arrangement, permitting Roche to keep on disseminating Sysmex hematology items, including instruments and reagents. This GBP sees the presentation of an IT Solutions Collaboration Agreement. In the recently characterized joint effort, the two organizations have co...

Read More

Cell and Gene Therapy

KANEKA EUROGENTEC ANNOUNCES THE SUCCESSFUL PRODUCTION OF 25G OF MRNA IN ONE BATCH

Kaneka Eurogentec | February 23, 2022

news image

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer. Eurogentec’s GMP mRNA manufacturing service offers in vitro transcription (IVT), purification, quality control and batch release of GMP material up to 25 g scale in its current facility in Belgium. In this project Eurogentec successfully produced and purified 25 g of mate...

Read More

Cell and Gene Therapy, Industrial Impact

AZENTA ANNOUNCES LAUNCH OF CRYO STORE PICO

Azenta Life Sciences | February 28, 2023

news image

On February 27, 2023, Azenta Life Sciences, a leading provider of life sciences solutions, announced the launch of its latest automated cryogenic storage system, the Cryo Store PicoTM. This new product is designed to store high-value biological samples used throughout various stages of the life sciences industry, from research and development to clinical use. Azenta is already known for providing innovative automated cryogenic solutions such as the BioStore™ III...

Read More
news image

Medical

DNA-ENCODED LIBRARIES (DELS) AND NANOBRET TARGET ENGAGEMENT ASSAYS ACCELERATE DRUG DISCOVERY

Businesswire | August 03, 2023

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery. Reported in Cell Chemical Biology, researchers from Promega Corporation and WuXi AppTec generated new chemical probes from molecules identified through a DEL screen. This research opens new opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied classes of proteins, rapidly accelerating “h...

Read More
news image

MedTech

ROCHE SIGNS AN AGREEMENT WITH SYSMEX TO BRING HAEMATOLOGY TESTING INNOVATIONS GLOBALLY

Roche | January 25, 2021

Roche declares that, on 14 December, 2020, it marked a Global Business Partnership Agreement* (GBP) with Sysmex. Under this new system, the gatherings restored their obligation to the long standing Distribution, Sales and Service (DSS) arrangement, permitting Roche to keep on disseminating Sysmex hematology items, including instruments and reagents. This GBP sees the presentation of an IT Solutions Collaboration Agreement. In the recently characterized joint effort, the two organizations have co...

Read More
news image

Cell and Gene Therapy

KANEKA EUROGENTEC ANNOUNCES THE SUCCESSFUL PRODUCTION OF 25G OF MRNA IN ONE BATCH

Kaneka Eurogentec | February 23, 2022

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer. Eurogentec’s GMP mRNA manufacturing service offers in vitro transcription (IVT), purification, quality control and batch release of GMP material up to 25 g scale in its current facility in Belgium. In this project Eurogentec successfully produced and purified 25 g of mate...

Read More
news image

Cell and Gene Therapy, Industrial Impact

AZENTA ANNOUNCES LAUNCH OF CRYO STORE PICO

Azenta Life Sciences | February 28, 2023

On February 27, 2023, Azenta Life Sciences, a leading provider of life sciences solutions, announced the launch of its latest automated cryogenic storage system, the Cryo Store PicoTM. This new product is designed to store high-value biological samples used throughout various stages of the life sciences industry, from research and development to clinical use. Azenta is already known for providing innovative automated cryogenic solutions such as the BioStore™ III...

Read More